Context · Startups · sweep Tuesday, November 17, 2026
European venture capital rounds in startups and biotech
Three European funds and platforms concentrate growth capital —Pigment, Nevis and Forbion's biotech fund—, a sign that European venture is scaling ticket size while capital shifts toward regulated and infrastructure sectors. It matters because European financing capacity defines the bloc's technological autonomy vis-à-vis the U.S. and China.
Title, thesis and gravity assessment written by an AI model, without prior human review.
Gravity58/100 · Context
Why this gravity
Tres eventos de fundraising: Pigment $250M Series E, Forbion $2.6B (mayor fondo de su historia) y Nevis $70M con EQT Ventures y QuantumLight. Volúmenes relevantes para el venture europeo pero son rondas de capital, no eventos que reordenen la industria ni obliguen acción inmediata del operador.
- Coverage
- 2 feeds · 2 independent publisher groups (corroborated)
- Cross verticals
- Startups, Investing, Lifespan & Healthspan
- Gravity vs. the previous edition
- no change (58)
coverage, not accuracy
Lead source
Pigment raises $250m Series E led by Scaleup Europe Fund · Sifted (European startups)More: STAT News
Timeline · Madrid time
- 15:42
- 12:27Pigment raises $250m Series E led by Scaleup Europe Fund · Sifted (European startups)
- 17:57EQT Ventures and QuantumLight back wealthtech platform Nevis in $70m raise · Sifted (European startups)
ShareWhatsApp
Related stories
- 65Revolut between regulatory scrutiny, record valuation and crypto expansion
- 60European venture capital in defense and AI agents
- 58Nvidia as venture capital and guarantor of European AI infrastructure
- 58European and Spanish public capital toward scaleups and strategic technology
- 55Record venture capital funds to finance AI expansion